Realizing the potential of clean mastered data for businesses

Subscribe to get the latest ideas and updates from Tamr.

Archive

Tamr CDISC Conversion Solution

Tamr’s CDISC Conversion Solution tackles data challenges with a powerful data harmonization process, driven by human-guided machine learning that can replace traditional in-house tools prone to delays and errors.

May 8, 2019

Tamr for CDISC White Paper

In the United States, the FDA requires that every clinical trial or application to market a new drug or biologic be accompanied by clinical study data showing the safety and efficacy of the proposed product. Converting clinical data into the…

Oct 31, 2016

BioPharma Case Study

Tamr was approached by a multinational biopharmaceutical company to transform the process of preparing its clinical data for analytics. The organization wanted to analyze the trove of unmined clinical trial and biomarker data in order to more effectively guide translational…

Oct 26, 2016

Integrating Biomedical Data through Human + Machine Intelligence

Presenting A New Approach to Taming Biomedical Data Variety Tamr Field Engineer Timothy Danford, Ph.D., discusses how Data Variety — the natural, siloed nature of data as it’s created — is creating a bottleneck to biomedical data analytics. Rule-based, deterministic…

Apr 29, 2015 Featured Content

CDISC Webinar

For most pharmaceutical companies, submitting clinical study data to the FDA is an expensive and time-consuming process. A study sponsor must collect data from different sources, extract it from proprietary file formats, transform it to conform to CDISC standards, organize…

Mar 4, 2015 Web Seminar

CDISC Data Sheet

Clinical Trial Data: Automated, Replicable CDISC Conversion Synopsis + IND and NDA programs necessitate recurrent submission of clinical trial data to regulatory agencies in specific formats. + Trial data is stored in a tangled web of standards, versions, and file…

Feb 16, 2015 Featured Content

Webinar: Toward Automated, Scalable CDISC Conversion

Watch Now » For most pharmaceutical companies, submitting clinical study data to the FDA is an expensive and time-consuming process. A study sponsor must collect data from different sources, extract it from proprietary file formats, transform it to conform to…

Jan 8, 2015 Featured Content

For Pharmaceutical Company, Tamr Enables Faster Data Connections and Drives a Cultural Shift Around Data Quality and Accessibility

An international pharmaceutical company has a massive problem: critical research data from thousands of scientists in labs spread across the globe is trapped in tens of thousands of spreadsheets. Associates need to quickly find critical data on compounds, assays and…

May 17, 2014 Case Studies